Search results
Results from the WOW.Com Content Network
[[Category:COVID-19 vaccine templates]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:COVID-19 vaccine templates]]</noinclude> to the end of the template code, making sure it starts on the same line as the code's last character.
Place a stub template at the very end of the article, after the "External links" section, any navigation templates, and the category tags. As usual, templates are added by including their name inside double braces, e.g. {{COVID19-vaccine-stub}}.
A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received the shot(s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.
COVID-19 Vaccination Record Card: Image title: COVID-19 Vaccination Record Card: Author: CDC/NCIRD: Software used: Adobe InDesign CC 13.0 (Windows) Conversion program: Adobe PDF Library 15.0: Encrypted: no: Page size: 348 x 294 pts: Version of PDF format: 1.4
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
By default, the template will state simply, "This user has been vaccinated against COVID-19." You can also add an optional |first-dose= parameter to make it say that you've only received the first of two doses. There are also |booster= options (see below) that you can use to be more specific on your vaccination journey.
COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially approved by the Food and Drug Administration (FDA) on August 23, 2021. [24] Studies have shown them to be highly protective against severe illness, hospitalization, and death.